Hans Martin Seidel - Mar 6, 2023 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Robert Ho, Attoney-in-Fact
Stock symbol
THRD
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
4
Date filed
3/8/2023, 04:03 PM
Previous filing
Oct 27, 2022
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Employee Stock Option (right to buy) Disposed to Issuer -6.64K -100% 0 Mar 6, 2023 Common Stock 6.64K $9.22 Direct F1, F2
transaction THRD Employee Stock Option (right to buy) Award +6.64K 6.64K Mar 6, 2023 Common Stock 6.64K $4.20 Direct F1, F2
transaction THRD Employee Stock Option (right to buy) Disposed to Issuer -13.7K -100% 0 Mar 6, 2023 Common Stock 13.7K $17.83 Direct F1, F3
transaction THRD Employee Stock Option (right to buy) Award +13.7K 13.7K Mar 6, 2023 Common Stock 13.7K $4.20 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
F2 6.25% vest in quarterly installments over the 4-year period commencing on February 17, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F3 The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date.